{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T04:35:18Z","timestamp":1782534918540,"version":"3.54.5"},"reference-count":70,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>In recent decades, the burden of TB has been gradually declining; however, with the emergence of COVID-19 and ongoing political conflicts, including the war in Ukraine, the proper functioning of healthcare services and TB control programs has been jeopardized. Recently, research has emphasized the importance of hematological parameters associated with inflammation, which can be easily analyzed through routine blood tests. Combining these parameters may have predictive value for various diseases, including pulmonary tuberculosis and even help monitor the effectiveness of treatment. Since there is no single hematological or inflammatory biomarker that provides precise and dynamic information about the success or failure of treatment, identifying individual markers or sets of biomarkers with higher sensitivity and specificity is essential. This is particularly important since sputum culture conversion at two months remains insufficiently sensitive and microscopy conversion has limited sensitivity and specificity in detecting treatment failure. Also, the analysis of the impact of the standard directly observed treatment, short-course regimen on pathogenic mechanisms also focuses on how it influences the interaction between inflammation and oxidative tissue degradation, by measuring plasma levels of glutathione. Utilizing a combination of hematological, inflammatory, and antioxidant biomarkers offers significant insights into systemic inflammatory responses in pulmonary tuberculosis patients, both before commencing treatment and during the entire duration of antituberculosis therapy. Combining different inflammatory parameters into a multiple biomarker can significantly enhance the accuracy of predicting prognosis and response to antibiotic chemotherapy. Identifying an optimal combination of biomarkers with predictive value is crucial for assessing treatment response and evaluating the effectiveness of anti-TB medication. Rather than developing or testing a composite prediction model, this review summarizes reported performance metrics from individual studies and highlights priorities for future prospective validation of integrated biomarker panels.<\/jats:p>","DOI":"10.3390\/jcm15031017","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T11:35:42Z","timestamp":1769513742000},"page":"1017","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Integrated Approach of Hematological Parameters and Glutathione as Predictors of Pulmonary TB Evolution: A Comprehensive Review"],"prefix":"10.3390","volume":"15","author":[{"given":"Ionela Alina","family":"Grosu","sequence":"first","affiliation":[{"name":"Grigore T. Popa University of Medicine and Pharmacy Iasi, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona Elisabeta","family":"Dobrin","sequence":"additional","affiliation":[{"name":"Biochemistry Department, Clinical Hospital of Pulmonary Diseases, 700116 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9439-0590","authenticated-orcid":false,"given":"Corina","family":"Marginean","sequence":"additional","affiliation":[{"name":"Oncology and Palliative Care Department, George Emil Palade University of Medicine, Pharmacy, Science and Technology of T\u00e2rgu Mure\u0219, 540139 T\u00e2rgu Mure\u0219, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina Mihaela","family":"Esanu","sequence":"additional","affiliation":[{"name":"Grigore T. Popa University of Medicine and Pharmacy Iasi, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oana Elena","family":"Melinte","sequence":"additional","affiliation":[{"name":"Grigore T. Popa University of Medicine and Pharmacy Iasi, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8804-2663","authenticated-orcid":false,"given":"Ioan Emanuel","family":"Stavarache","sequence":"additional","affiliation":[{"name":"Grigore T. Popa University of Medicine and Pharmacy Iasi, 700115 Iasi, Romania"},{"name":"Department of Preclinical Disciplines, Faculty of Medicine, \u201cApollonia\u201d University of Ia\u015fi, 700511 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0292-2453","authenticated-orcid":false,"given":"Stefan","family":"Dumitrache-Rujinski","sequence":"additional","affiliation":[{"name":"Department of Pneumophtysiology I, \u201cCarol Davila\u201d University of Medicine and Pharmacy, Dionisie Lupu Street, Nr. 37, Sector 2, 020021 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6136-5204","authenticated-orcid":false,"given":"Ionel-Bogdan","family":"Cioroiu","sequence":"additional","affiliation":[{"name":"Romanian Academy-Iasi Branch, Research Center for Oenology, 700490 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3732-0350","authenticated-orcid":false,"given":"Radu Adrian","family":"Crisan-Dabija","sequence":"additional","affiliation":[{"name":"Grigore T. Popa University of Medicine and Pharmacy Iasi, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Vicol","sequence":"additional","affiliation":[{"name":"Grigore T. Popa University of Medicine and Pharmacy Iasi, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3252-7715","authenticated-orcid":false,"given":"Antigona Carmen","family":"Trofor","sequence":"additional","affiliation":[{"name":"Grigore T. Popa University of Medicine and Pharmacy Iasi, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (WHO) (2024). Global Tuberculosis Report 2024, World Health Organization. Available online: https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/tb-reports."},{"key":"ref_2","unstructured":"World Health Organization (WHO) (2023). Global Tuberculosis Report 2023, World Health Organization. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240083851."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"220166","DOI":"10.1183\/20734735.0166-2022","article-title":"Tuberculosis: Current challenges and beyond","volume":"19","author":"Ghodousi","year":"2023","journal-title":"Breathe"},{"key":"ref_4","unstructured":"European Centre for Disease Prevention and Control, and WHO Regional Office for Europe (2023). Tuberculosis Surveillance and Monitoring in Europe 2023\u20142021 Data, WHO Regional Office for Europe. Available online: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/tuberculosis-surveillance-monitoring-2023.pdf."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.2147\/IJN.S364634","article-title":"Innovative Therapeutic Approaches Based on Nanotechnology for the Treatment and Management of Tuberculosis","volume":"18","author":"Kia","year":"2023","journal-title":"Int. J. Nanomed."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"100395","DOI":"10.1016\/j.jctube.2023.100395","article-title":"Diagnostic value of the neutrophil lymphocyte ratio in discrimination between tuberculosis and bacterial community acquired pneumonia: A meta-analysis","volume":"33","author":"Shojaan","year":"2023","journal-title":"J. Clin. Tuberc. Other Mycobact. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Tu, H.Z., Lai, T.J., Chen, Y.S., Lee, H.S., and Chen, J.S. (2023). Hematological Parameters as Potential Markers for Distinguishing Pulmonary Tuberculosis from Genitourinary Tuberculosis. Pathogens, 12.","DOI":"10.3390\/pathogens12010084"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s10753-014-9978-y","article-title":"The relationship between inflammatory marker levels and pulmonary tuberculosis severity","volume":"38","author":"Abakay","year":"2014","journal-title":"Inflammation"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"102012","DOI":"10.1016\/j.redox.2021.102012","article-title":"New roles for glutathione: Modulators of bacterial virulence and pathogenesis","volume":"44","author":"Ku","year":"2021","journal-title":"Redox Biol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Abnousian, A., Vasquez, J., Sasaninia, K., Kelley, M., and Venketaraman, V. (2023). Glutathione Modulates Efficacious Changes in the Immune Response against Tuberculosis. Biomedicines, 11.","DOI":"10.20944\/preprints202304.0166.v1"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s11274-023-03636-x","article-title":"Clinical manifestations and immune response to tuberculosis","volume":"39","author":"Amado","year":"2023","journal-title":"World J. Microbiol. Biotechnol."},{"key":"ref_12","first-page":"E9","article-title":"The history of tuberculosis: From the first historical records to the isolation of Koch\u2019s bacillus","volume":"58","author":"Barberis","year":"2017","journal-title":"J. Prev. Med. Hyg."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1098\/rspb.2009.1484","article-title":"Tuberculosis in Dr Granville\u2019s mummy: A molecular re-examination of the earliest known Egyptian mummy to be scientifically examined and given a medical diagnosis","volume":"277","author":"Donoghue","year":"2010","journal-title":"Proc. R. Soc. B Biol. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Singh, M., Vaughn, C., Sasaninia, K., Yeh, C., Mehta, D., Khieran, I., and Venketaraman, V. (2020). Understanding the Relationship between Glutathione, TGF-\u03b2, and Vitamin D in Combating Mycobacterium tuberculosis Infections. J. Clin. Med., 9.","DOI":"10.3390\/jcm9092757"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1146\/annurev-immunol-032712-100022","article-title":"The Formation and Function of Granulomas","volume":"36","author":"Ramakrishnan","year":"2018","journal-title":"Annu. Rev. Immunol."},{"key":"ref_16","first-page":"290","article-title":"The Fl\u00fcgge\u2019s drops","volume":"47","year":"2009","journal-title":"Rev. Med. Inst. Mex. Seguro. Soc."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/s41579-022-00763-4","article-title":"Immune evasion and provocation by Mycobacterium tuberculosis","volume":"20","author":"Chandra","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/microbiolspec.GPP3-0022-2018","article-title":"Immunology of Mycobacterium tuberculosis Infections","volume":"7","author":"Sia","year":"2019","journal-title":"Microbiol. Spectr."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/resp.13303","article-title":"Epidemiological, clinical and mechanistic perspectives of tuberculosis in older people","volume":"23","author":"Yew","year":"2018","journal-title":"Respirology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMcp2108501","article-title":"Latent Tuberculosis Infection","volume":"385","author":"Shah","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"(2020). Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020. Recomm. Rep., 69, 1\u201311. Available online: https:\/\/www.cdc.gov\/mmwr\/volumes\/69\/rr\/rr6901a1.htm?s_cid=rr6901a1w.","DOI":"10.15585\/mmwr.rr6901a1"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Moule, M.G., and Cirillo, J.D. (2020). Mycobacterium tuberculosis Dissemination Plays a Critical Role in Pathogenesis. Front. Cell. Infect. Microbiol., 10.","DOI":"10.3389\/fcimb.2020.00065"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e25122","DOI":"10.1002\/jcla.25122","article-title":"Mycobacterium tuberculosis: The Mechanism of Pathogenicity, Immune Responses, and Diagnostic Challenges","volume":"38","author":"Mohammadnabi","year":"2024","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Miggiano, R., Rizzi, M., and Ferraris, D.M. (2020). Mycobacterium tuberculosis Pathogenesis, Infection Prevention and Treatment. Pathogens, 9.","DOI":"10.3390\/pathogens9050385"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.tim.2018.02.012","article-title":"Mycobacterium\u00a0tuberculosis","volume":"26","author":"Koch","year":"2018","journal-title":"Trends Microbiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"126674","DOI":"10.1016\/j.micres.2020.126674","article-title":"Human tuberculosis and Mycobacterium tuberculosis complex: A review on genetic diversity, pathogenesis and omics approaches in host biomarkers discovery","volume":"246","author":"Kanabalan","year":"2021","journal-title":"Microbiol. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/s41579-018-0013-4","article-title":"Metabolic principles of persistence and pathogenicity in Mycobacterium tuberculosis","volume":"16","author":"Ehrt","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"a018424","DOI":"10.1101\/cshperspect.a018424","article-title":"Innate and Adaptive Cellular Immune Responses to Mycobacterium tuberculosis Infection","volume":"5","author":"Barber","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1146\/annurev-immunol-093019-010426","article-title":"The Innate Immune Response to Mycobacterium tuberculosis Infection","volume":"39","author":"Stanley","year":"2021","journal-title":"Annu. Rev. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1007\/s11033-020-05413-7","article-title":"Advances in diagnosis of Tuberculosis: An update into molecular diagnosis of Mycobacterium tuberculosis","volume":"47","author":"Acharya","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.nmni.2017.07.002","article-title":"Evaluation of GeneXpert MTB\/RIF for determination of rifampicin resistance among new tuberculosis cases in west and northwest Iran","volume":"19","author":"Atashi","year":"2017","journal-title":"New Microbes New Infect."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.immuni.2016.09.014","article-title":"Macrophage Epithelial Reprogramming Underlies Mycobacterial Granuloma Formation and Promotes Infection","volume":"45","author":"Cronan","year":"2016","journal-title":"Immunity"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s10517-014-2435-y","article-title":"Fibrogenesis in granulomas and lung interstitium in tuberculous inflammation in mice","volume":"156","author":"Shkurupiy","year":"2014","journal-title":"Bull. Exp. Biol. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1111\/febs.16369","article-title":"Secretory proteins of Mycobacterium tuberculosis and their roles in modulation of host immune responses: Focus on therapeutic targets","volume":"289","author":"Pal","year":"2022","journal-title":"FEBS J."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/icb.2014.52","article-title":"Outcome of Mycobacterium tuberculosis and Toll-like receptor interaction: Immune response or immune evasion?","volume":"92","author":"Saraav","year":"2014","journal-title":"Immunol. Cell Biol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1128\/microbiolspec.MGM2-0005-2013","article-title":"Evasion of Innate and Adaptive Immunity by Mycobacterium tuberculosis","volume":"2","author":"Goldberg","year":"2014","journal-title":"Microbiol. Spectr."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.smim.2014.09.002","article-title":"Crosstalk between Mycobacterium tuberculosis and the host cell","volume":"26","author":"Dey","year":"2014","journal-title":"Semin. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Yu, Z., Shang, Z., Huang, Q., Wen, F., and Patil, S. (2024). Integrating systemic immune-inflammation index, fibrinogen, and T-SPOT.TB for precision distinction of active pulmonary tuberculosis in the era of mycobacterial disease research. Front. Microbiol., 15.","DOI":"10.3389\/fmicb.2024.1382665"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Ye, C., Yuan, L., Wu, K., Shen, B., and Zhu, C. (2023). Association between systemic immune-inflammation index and chronic obstructive pulmonary disease: A population-based study. BMC Pulm. Med., 23.","DOI":"10.1186\/s12890-023-02583-5"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e40349","DOI":"10.1097\/MD.0000000000040349","article-title":"Predictive value of systemic immune-inflammatory biomarkers for drug-induced liver injury in hepatitis B virus surface antigen positive tuberculosis patients: A retrospective observational study","volume":"103","author":"Dong","year":"2024","journal-title":"Medicine"},{"key":"ref_41","first-page":"231","article-title":"Systemic immune-inflammation index as a potential biomarker for predicting acute pulmonary embolism: A systematic review","volume":"62","author":"Suwadi","year":"2024","journal-title":"Rom. J. Intern. Med."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"\u015etefanescu, S., Coco\u015f, R., Turcu-Stiolica, A., Mahler, B., Meca, A.-D., Giura, A.M.C., Bogdan, M., Shelby, E.S., Zamfirescu, G., and Pisoschi, C.-G. (2021). Evaluation of prognostic significance of hematological profiles after the intensive phase treatment in pulmonary tuberculosis patients from Romania. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0249301"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"798","DOI":"10.2174\/0113862073286907240308095907","article-title":"Effect of Novel Inflammatory Biomarkers on Adverse Outcomes in Patients with Interstitial Lung Disease and Pneumonia: A Multicenter Retrospective Cohort Study","volume":"28","author":"Bai","year":"2024","journal-title":"Comb. Chem. High Throughput Screen"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.2217\/fon-2018-0285","article-title":"Prognostic value of systemic immune-inflammation index in patients with advanced non-small-cell lung cancer","volume":"14","author":"Guo","year":"2018","journal-title":"Futur. Oncol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Biswas, T., Kang, K.H., Gawdi, R., Bajor, D., Machtay, M., Jindal, C., and Efird, J.T. (2020). Using the Systemic Immune-Inflammation Index (SII) as a Mid-Treatment Marker for Survival among Patients with Stage-III Locally Advanced Non-Small Cell Lung Cancer (NSCLC). Int. J. Environ. Res. Public Health, 17.","DOI":"10.3390\/ijerph17217995"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.smim.2014.04.003","article-title":"Tumor necrosis factor alpha in mycobacterial infection","volume":"26","author":"Dorhoi","year":"2014","journal-title":"Semin. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.2147\/IJGM.S483185","article-title":"Association between indices of peripheral blood inflammation and cavitary pulmonary tuberculosis","volume":"17","author":"He","year":"2024","journal-title":"Int. J. Gen. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1164\/rccm.201710-2102OC","article-title":"Platelets Regulate Pulmonary Inflammation and Tissue Destruction in Tuberculosis","volume":"198","author":"Fox","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Ji, Y., Xie, Q., Wei, W., Huang, Z., Liu, X., Ye, Q., Liu, Y., Lu, X., Lu, Y., and Hou, R. (2025). Association between blood inflammatory status and the survival of tuberculosis: A five-year cohort study. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1556857"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"298","DOI":"10.51601\/ijhp.v5i2.386","article-title":"Analysis of Systemic Immune-Inflammation Index (Sii) And Cd4 Count In Hiv\/Aids Patients With And Without Tuberculosis Co-Infection","volume":"5","author":"Fathiyah","year":"2025","journal-title":"Int. J. Health Pharm. (IJHP)"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Stanciu, I.-V., Fildan, A.-P., Thakur, B.R., Ilie, A.C., Stanga, L., Oancea, C., Tudorache, E., Bratosin, F., Rosca, O., and Bogdan, I. (2025). Full-Blood Inflammatory Ratios Predict Length of Stay but Not Early Death in Romanian Pulmonary Tuberculosis. Medicina, 61.","DOI":"10.3390\/medicina61071238"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.2147\/JIR.S468232","article-title":"A Novel Inflammatory Indicator for Tuberculosis-Associated Obstructive Pulmonary Disease (TOPD): The Systemic Inflammatory Response Index (SIRI)","volume":"17","author":"Hu","year":"2024","journal-title":"J. Inflamm. Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.2147\/CMAR.S287897","article-title":"Systemic Inflammation Response Index (SIRI) Independently Predicts Survival in Advanced Lung Adenocarcinoma Patients Treated with First-Generation EGFR-TKIs","volume":"13","author":"Jiang","year":"2021","journal-title":"Cancer Manag. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e33372","DOI":"10.1097\/MD.0000000000033372","article-title":"Evaluation of prognostic inflammatory and systemic inflammatory response indices in auxiliary diagnosis of bacteria-negative pulmonary tuberculosis: A diagnostic accuracy study","volume":"102","author":"Chai","year":"2023","journal-title":"Medicine"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2147\/JIR.S434720","article-title":"Role of the Systemic Inflammatory Response Index in Predicting Disease Severity and Prognosis in Idiopathic Pulmonary Arterial Hypertension","volume":"17","author":"Gao","year":"2024","journal-title":"J. Inflamm. Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"226","DOI":"10.32552\/2023.ActaMedica.932","article-title":"Prognostic importance of systemic immune inflammation index in chronic obstructive pulmonary disease","volume":"54","author":"Celtikci","year":"2023","journal-title":"Acta Medica"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.2147\/IDR.S459330","article-title":"Construction and Validation of a Nomogram to Identify the Risk of Cavitation in Pulmonary Tuberculosis","volume":"17","author":"Song","year":"2024","journal-title":"Infect. Drug Resist."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"116946","DOI":"10.1016\/j.diagmicrobio.2025.116946","article-title":"Establishment and evaluation of a diagnostic model for severe pulmonary tuberculosis","volume":"113","author":"Wang","year":"2025","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_59","first-page":"2867","article-title":"The Inflammatory Prognostic Index Predicts Cancer-Specific Outcomes of Patients with Resected Non-Small Cell Lung Cancer","volume":"19","author":"Tomita","year":"2018","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Guerra, C., Morris, D., Sipin, A., Kung, S., Franklin, M., Gray, D., Tanzil, M., Guilford, F., Khasawneh, F.T., and Venketaraman, V. (2011). Glutathione and adaptive immune responses against Mycobacterium tuberculosis infection in healthy and HIV infected individuals. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0028378"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1128\/IAI.71.4.1864-1871.2003","article-title":"Role of glutathione in macrophage control of mycobacteria","volume":"71","author":"Venketaraman","year":"2003","journal-title":"Infect. Immun."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"734125","DOI":"10.1155\/2012\/734125","article-title":"Unveiling the mechanisms for decreased glutathione in individuals with HIV infection","volume":"2012","author":"Morris","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Allen, M., Bailey, C., Cahatol, I., Dodge, L., Yim, J., Kassissa, C., Luong, J., Kasko, S., Pandya, S., and Venketaraman, V. (2015). Mechanisms of Control of Mycobacterium tuberculosis by NK Cells: Role of Glutathione. Front. Immunol., 6.","DOI":"10.3389\/fimmu.2015.00508"},{"key":"ref_64","first-page":"1462","article-title":"The roles of glutathione, glutathione peroxidase, glutathione reductase and the carbonyl protein in pulmonary and extra pulmonary tuberculosis","volume":"6","author":"Dalvi","year":"2012","journal-title":"J. Clin. Diagn. Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.micpath.2007.09.002","article-title":"Glutathione levels and immune responses in tuberculosis patients","volume":"44","author":"Venketaraman","year":"2008","journal-title":"Microb. Pathog."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1007\/s12011-020-02254-0","article-title":"Oxidative Stress and Trace Elements in Pulmonary Tuberculosis Patients During 6 Months Anti-tuberculosis Treatment","volume":"199","author":"Qi","year":"2020","journal-title":"Biol. Trace Element Res."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Meca, A.-D., Turcu-Stiolica, A., Stanciulescu, E.C., Andrei, A.M., Nitu, F.M., Banita, I.M., Matei, M., and Pisoschi, C.-G. (2021). Variations of Serum Oxidative Stress Biomarkers under First-Line Antituberculosis Treatment: A Pilot Study. J. Pers. Med., 11.","DOI":"10.3390\/jpm11020112"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jmii.2021.07.004","article-title":"Personalized profiles of antioxidant signaling pathway in patients with tuberculosis","volume":"55","author":"Petrillo","year":"2022","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1742-6405-3-5","article-title":"Glutathione and growth inhibition of Mycobacterium tuberculosis in healthy and HIV infected subjects","volume":"3","author":"Venketaraman","year":"2006","journal-title":"AIDS Res. Ther."},{"key":"ref_70","unstructured":"(2013). Medical laboratories\u2014Requirements for quality and competence (Standard No. ISO 15189:2013)."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/3\/1017\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T11:42:45Z","timestamp":1769514165000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/3\/1017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":70,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["jcm15031017"],"URL":"https:\/\/doi.org\/10.3390\/jcm15031017","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]}}}